US 10,479,805 B2Granted

Beta-lactamase inhibitor

AssigneeWuhan Vision Pharmaceutical Technology Co., Ltd.

InventorsShiping Wu, Hongyu Xu, Xiangdong Hu

Life of this patent

Estimating the term…

Abstract

A beta-lactamase inhibitor having a formula (I). Also provided is a method of using the beta-lactamase inhibitor for prevention or treatment of diseases.

Claims1

Dependent claims

A compound having a formula of:

Dependencies are inferred from the claim text.

Facts

Application: 16/164,929Filed 19 Oct 2018 · continuation in part
Priority: CN 2016 1 024309319 Apr 2016
Published: US 2019/0048027 A114 Feb 2019
Granted: 19 Nov 2019
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07F 5/025
Boron compounds: boronic and borinic acid compounds
A61K 31/69
Medicinal preparations containing organic active ingredients: boron compounds
A61P 31/04
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antibacterial agents
C07F 5/02
Compounds containing elements of Groups 3 or 13 of the Periodic Table: boron compounds

Family

PCT/CN2017/080337Parent of this continuation-in-part · filed 13 Apr 2017
US 2019/0048027 A1Pre-grant publication · published 14 Feb 2019
US 10,479,805 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…